NEUROFIBROMATOSIS TYPE-2 PROTEIN COLOCALIZES WITH ELEMENTS OF THE CYTOSKELETON

被引:0
|
作者
DENBAKKER, MA
TASCILAR, M
RIEGMAN, PHJ
HEKMAN, ACP
BOERSMA, W
JANSSEN, PJA
DEJONG, TAW
HENDRIKS, W
VANDERKWAST, TH
ZWARTHOFF, EC
机构
[1] ERASMUS UNIV ROTTERDAM, DEPT PATHOL, 3000 DR ROTTERDAM, NETHERLANDS
[2] TNO PG, DIV 1, LEIDEN, NETHERLANDS
[3] TNO PG, DIV 2, LEIDEN, NETHERLANDS
[4] UNIV NIJMEGEN, DEPT CELL BIOL & HISTOL, NIJMEGEN, NETHERLANDS
来源
AMERICAN JOURNAL OF PATHOLOGY | 1995年 / 147卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The product of the neurofibromatosis type 2 (NF2) tumor suppressor gene is a 595-amino-acid protein bearing resemblance to a family of band-4.1-related proteins. These proteins, including ezrin, radixin, and moesin, probably function as molecular linking proteins, connecting the cytoskeleton to the cell membrane. On the grounds of the homology to the ezrin, radixin, and moesin proteins and on the basis of its predicted secondary structure, the NF2 protein is also thought to act a a cytoskeleton-cell membrane linking protein. Using monoclonal antibodies to amino -and carboxyl-terminal synthetic NF2 peptides we demonstrate the co-localization of the NF2 protein with elements of the cytoskeleton in a COS cell model system and in cultured human cells. Furthermore, the presence of the NF2 protein in tissue sections is shown. The monoclonal antibodies specifically stain smooth muscle cells and the stratum granulosum of the human epidermis. In cultured smooth muscle cells the NF2 protein co-localizes with actin stress fibers. Immunoelectron microscopy demonstrates the presence of the NF2 protein associated with keratohyalin granules and to a lesser extent with intermediate filaments in the human epidermis. We conclude that the NF2 protein is indeed associated with multiple elements of the cytoskeleton.
引用
收藏
页码:1339 / 1349
页数:11
相关论文
共 50 条
  • [41] PRECISE MAPPING OF THE NEUROFIBROMATOSIS TYPE-2 LOCUS ON CHROMOSOME-22
    ROULEAU, GA
    SEIZINGER, BR
    WERTELECKI, W
    HAINES, JL
    SUPERNEAU, DW
    MARTUZA, RL
    GUSELLA, JF
    CYTOGENETICS AND CELL GENETICS, 1989, 51 (1-4): : 1070 - 1070
  • [42] THERE IS NO NON-ALLELIC GENETIC-HETEROGENEITY IN NEUROFIBROMATOSIS TYPE-2
    ROULEAU, GA
    NAROD, SA
    FAUCHER, MC
    HAINES, JA
    GUSELLA, JF
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 357 - 357
  • [43] GERMLINE MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 TUMOR-SUPPRESSOR GENE
    BOURN, D
    CARTER, SA
    MASON, S
    EVANS, DGR
    STRACHAN, T
    HUMAN MOLECULAR GENETICS, 1994, 3 (05) : 813 - 816
  • [44] DIAGNOSTIC ISSUES IN A FAMILY WITH LATE-ONSET TYPE-2 NEUROFIBROMATOSIS
    EVANS, DGR
    BOURN, D
    WALLACE, A
    RAMSDEN, RT
    MITCHELL, JD
    STRACHAN, T
    JOURNAL OF MEDICAL GENETICS, 1995, 32 (06) : 470 - 474
  • [45] THE MOUSE NEUROFIBROMATOSIS TYPE-2 GENE MAPS TO CHROMOSOME-11
    CLAUDIO, JO
    MALO, D
    ROULEAU, GA
    GENOMICS, 1994, 21 (02) : 437 - 439
  • [46] IDENTIFYING AND CHARACTERIZING MUTATIONS IN THE MERLIN GENE IN PATIENTS WITH TYPE-2 NEUROFIBROMATOSIS
    STRACHAN, T
    BOURN, D
    CARTER, S
    CARETTE, M
    WATSON, C
    HARRIS, R
    EVANS, DGR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 372 - 372
  • [47] NEUROFIBROMATOSIS TYPE-2 - REPORT OF A FAMILY AND REVIEW OF CURRENT EVALUATION AND TREATMENT
    MCKENNAN, KX
    BARD, A
    LARYNGOSCOPE, 1991, 101 (02): : 109 - 113
  • [48] WIDESPREAD BUT CELL-TYPE-SPECIFIC EXPRESSION OF THE MOUSE NEUROFIBROMATOSIS TYPE-2 GENE
    CLAUDIO, JO
    LUTCHMAN, M
    ROULEAU, GA
    NEUROREPORT, 1995, 6 (14) : 1942 - 1946
  • [49] BILATERAL OPTIC-NERVE SHEATH MENINGIOMAS IN A PATIENT WITH NEUROFIBROMATOSIS TYPE-2
    CUNLIFFE, IA
    MOFFAT, DA
    HARDY, DG
    MOORE, AT
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1992, 76 (05) : 310 - 312
  • [50] NO EVIDENCE FOR LINKAGE TO THE TYPE-1 OR TYPE-2 NEUROFIBROMATOSIS LOCI IN NOONAN SYNDROME FAMILIES
    FLINTOFF, WF
    BAHUAU, M
    LYONNET, S
    GILGENKRANTZ, S
    LACOMBE, D
    MARCON, F
    LEVILLIERS, J
    KACHANER, J
    MUNNICH, A
    LEMERRER, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 46 (06): : 700 - 705